Our P2Med fellows were invited to participate in a conference organised by IMIBIC’s PhD Programme in Biomedicine. The aim was to promote and foster the internationalisation of the Programme, and it was targeted at PhD students from…
New Research Article
Type 2 diabetes mellitus (T2DM) is one of the most widely spread diseases, affecting around 90% of the patients with diabetes. Metabolomics has proven useful in diabetes research discovering new biomarkers to assist in therapeutical studies and elucidating pathways of…
IMIBIC-P2Med programme featured in EU Research magazine
This autumn 2022 issue of the EU Research magazine includes an article about our Post-doc Programme IMIBIC-P2Med. We are halfway through our programme and all our fellows have started their research projects and training. We are pleased to have the…
